Sleep, Diet, and Exercise These are three important lifestyle habits to manage your migraine headaches. Get enough sleep.Regularly getting about 8 hours a night may cut down the number and ...

Here’s how it works. It's 2025 but both the iPhone 14 Pro and iPhone 13 Pro could still be worth buying or holding onto if you're looking into upgrading. Check out our review of the iPhone 16 ...

Scientists haven’t found a cure for migraines, but they’re better at treating the symptoms. In fact, they’ve made more advances in migraine treatment in the last 2 years than in the previous ...

Even in 2025, the iPhone 14 and iPhone 14 Plus could still be phones worthy of consideration if you're wanting to avoid splashing out on Apple's latest and greatest. If you need help deciding ...

Ubrelvy (ubrogepant) and Nurtec (rimegepant) are prescription medications approved to help manage and offer relief for people dealing with migraine headaches with or without aura. Both belong to a ...

Meanwhile, two oral CGRP inhibitors – AbbVie’s Ubrelvy and BioHaven’s Nurtec – have been launched for the on-demand treatment of acute migraine attacks. These don’t compete with Aimovig ...

It was alleged the providers then tried to persuade their colleagues to prescribe Nurtec to Medicaid and other federal health care beneficiaries — a violation of the Anti-Kickback Statute.

Here’s how it works. You'll find all of this week's best iPhone 14 Plus deals rounded up into one handy resource right here on this page - including both big and small carriers. Even those this ...

Here’s how it works. We've rounded up all of this week's best iPhone 14 deals into one handy page right here - perfect for those looking to pick up this still-great device on a budget.

Pharma giant Pfizer has agreed to pay $59 million to settle a federal lawsuit accusing a local biopharmaceutical company of paying “kickbacks” to healthcare providers to induce them to prescribe its ...

Other products such as Eliquis, Nurtec, Vyndaqel and Ibrance helped drive the sales beat, as well. On the flip side, vaccines Prevnar and Abrysvo underperformed expectations. Pfizer expects $1B ...

Nurtec ODT/Vydura globally, up 39% operationally, driven primarily by strong demand in the U.S. and, to a much lesser extent, recent launches in international markets, partially offset by lower ...